KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Receivables - Net: 2017-2025

Historic Receivables - Net for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $115.6 million.

  • Guardant Health's Receivables - Net rose 30.66% to $115.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.6 million, marking a year-over-year increase of 30.66%. This contributed to the annual value of $110.3 million for FY2024, which is 24.18% up from last year.
  • Per Guardant Health's latest filing, its Receivables - Net stood at $115.6 million for Q3 2025, which was down 11.26% from $130.3 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Receivables - Net peaked at $130.3 million during Q2 2025, and registered a low of $48.0 million during Q1 2021.
  • Over the past 3 years, Guardant Health's median Receivables - Net value was $88.8 million (recorded in 2023), while the average stood at $99.7 million.
  • As far as peak fluctuations go, Guardant Health's Receivables - Net soared by 83.22% in 2021, and later fell by 9.24% in 2023.
  • Guardant Health's Receivables - Net (Quarterly) stood at $97.7 million in 2021, then declined by 0.41% to $97.3 million in 2022, then dropped by 8.71% to $88.8 million in 2023, then rose by 24.18% to $110.3 million in 2024, then soared by 30.66% to $115.6 million in 2025.
  • Its last three reported values are $115.6 million in Q3 2025, $130.3 million for Q2 2025, and $115.4 million during Q1 2025.